INVERNIZZI PIETRO

Posizione organizzativa: 
Ruolo: 
Professore ordinario
Settore scientifico disciplinare: 
GASTROENTEROLOGIA (MED/12)
Telefono: 
0264488139
0264488089
Stanza: 
U08, Piano: P03, Stanza: 3019
Via Cadore, 48 - 20900 MONZA
U08, Piano: P03, Stanza: 3020
Via Cadore, 48 - 20900 MONZA

Didattica

Pubblicazioni

  • Pastore, M., Lori, G., Gentilini, A., Taddei, M., Di Maira, G., Campani, C., et al. (2020). Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives. CELLS, 9(3). Dettaglio
  • Pares, A., Shiffman, M., Vargas, V., Invernizzi, P., Malecha, E., Liberman, A., et al. (2020). Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis. LIVER INTERNATIONAL. Dettaglio
  • Cristoferi, L., & Invernizzi, P. (2020). Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis". DISEASE MARKERS, 2020. Dettaglio
  • Murillo Perez, C., Harms, M., Lindor, K., van Buuren, H., Hirschfield, G., Corpechot, C., et al. (2020). Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase. AMERICAN JOURNAL OF GASTROENTEROLOGY, 115(7), 1066-1074. Dettaglio
  • Massironi, S., Pilla, L., Elvevi, A., Longarini, R., Rossi, R., Bidoli, P., et al. (2020). New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma. CELLS, 9(3). Dettaglio